elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q58803847-B82E8BCC-DB3A-4ED8-A1E1-A86BA75F734D
Q58803847-B82E8BCC-DB3A-4ED8-A1E1-A86BA75F734D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58803847-B82E8BCC-DB3A-4ED8-A1E1-A86BA75F734D
Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin
P2860
Q58803847-B82E8BCC-DB3A-4ED8-A1E1-A86BA75F734D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58803847-B82E8BCC-DB3A-4ED8-A1E1-A86BA75F734D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9091828b2f4938e4525d2180a85dd964ef1636af
P2860
Ridinilazole: a novel therapy for Clostridium difficile infection